Terumo Corporation (TRUMY)
OTCMKTS · Delayed Price · Currency is USD
18.09
-0.07 (-0.39%)
Aug 28, 2025, 3:42 PM EDT
Terumo Market Cap
Terumo has a market cap or net worth of $26.69 billion as of August 28, 2025. Its market cap has increased by 6.85% in one year.
Market Cap
26.69B
Enterprise Value
26.72B
Revenue
7.19B
Ranking
n/a
PE Ratio
30.82
Stock Price
$18.09
Market Cap Chart
Since July 29, 1993, Terumo's market cap has increased from 1.86B to 26.69B, an increase of 1,334.42%. That is a compound annual growth rate of 8.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 26.69B | -7.13% |
| Dec 30, 2024 | 28.73B | 17.78% |
| Dec 29, 2023 | 24.40B | 15.35% |
| Dec 30, 2022 | 21.15B | -33.74% |
| Dec 30, 2021 | 31.92B | 1.22% |
| Dec 30, 2020 | 31.54B | 18.06% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 838.96M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 654.83M |
| Elite Pharmaceuticals | 610.28M |
| CytoDyn | 396.18M |
| Northwest Biotherapeutics | 390.55M |
| American Oncology Network | 359.30M |